OATP1B1-related drug–drug and drug–gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis

OBJECTIVE: Genetic variation in drug metabolizing enzymes and membrane transporters as well as concomitant drug therapy can modulate the beneficial and the deleterious effects of drugs. We investigated whether patients exhibiting rhabdomyolysis who were taking cerivastatin possess functional genetic...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Tamraz, Bani, Fukushima, Hisayo, Wolfe, Alan R., Kaspera, Rüdiger, Totah, Rheem A., Floyd, James S., Ma, Benjamin, Chu, Catherine, Marciante, Kristin D., Heckbert, Susan R., Psaty, Bruce M., Kroetz, Deanna L., Kwok, Pui-Yan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3894639/
https://ncbi.nlm.nih.gov/pubmed/23652407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e3283620c3b
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia